The US Food and Drug Administration (FDA) approved the first-ever anti-depression nasal spray, Spravato. The pharmaceutical ...
Public trust in a federal access program for the overdose drug Naloxone has been shaken after more than a year of shortages ...
Hosted on MSN3d
FDA approves 'ketamine' nasal spray for depression — here's everything you need to knowA nasal spray that contains esketamine — a potent derivative of ketamine — can now be taken on its own to treat adults with ...
Discover how the dry air of winter affects your nose and how to combat the drying out with helpful tips and treatments.
The U.S. Food and Drug Administration recently expanded approval of the nasal spray SPRAVATO, a ketamine-derived drug, as a ...
A new purple box graces the parish hall of Christ Church Cooperstown. It contains boxes of naloxone — brand name Narcan — ...
People with treatment-resistant depression can now take Spravato's ketamine-derived nasal spray as a standalone treatment.
PDUFA date of March 27, 2025 for CARDAMYST™ (etripamil) nasal spray for Paroxysmal Supraventricular Tachycardia (PSVT)- Commercial capabilities ...
PDUFA date of March 27, 2025 for CARDAMYST (etripamil) nasal spray for Paroxysmal Supraventricular Tachycardia (PSVT) - Commercial capabilities build out in process, with proposed launch in PSVT targe ...
The UK-based consumer healthcare company will be modernizing its facility along Brook Road, where it conducts R&D for such ...
Boing Boing on MSN10d
FDA approves J&J's patented psychedelic esketamine for depression without requiring you take other antidepressants with itOn Tuesday, the US Food and Drug Administration (FDA) approved Johnson & Johnson's hallucinogenic drug esketamine (brand name ...
Researchers delivered a dose of the “love hormone” oxytocin via a nasal spray to participants and found that it decreased ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback